Cite
HARVARD Citation
Jayne, D. et al. (2014). OP0227 Oral C5a Receptor Antagonist CCX168 Phase 2 Clinical TRIAL in Anca-Associated Renal Vasculitis. Annals of the rheumatic diseases. p. 148. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Jayne, D. et al. (2014). OP0227 Oral C5a Receptor Antagonist CCX168 Phase 2 Clinical TRIAL in Anca-Associated Renal Vasculitis. Annals of the rheumatic diseases. p. 148. [Online].